BioCorRx 

$0.2100
7
+$0.01+4.48% Monday 15:25

Statistics

Day High
0.201
Day Low
0.201
52W High
1.28
52W Low
0.152
Volume
100
Avg. Volume
3,273
Mkt Cap
6.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.07
-0.06
-0.06
-0.05
Expected EPS
-0.05
Actual EPS
N/A

Financials

-431.62%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
797,000Revenue
-3.44MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery. Additionally, the company provides the UnCraveRx weight management program, a medically supported initiative designed to curb food cravings. This program integrates pharmacological assistance with readily available virtual support focusing on lifestyle adjustments, fitness, and nutritional guidance. Looking to the future, BioCorRx is actively advancing its product pipeline. This includes BICX101, an injectable naltrexone product, and BICX104, an implantable naltrexone device, both currently under development for the specific treatment of opioid addiction and alcoholism. The company's programs are made available to patients through a network of healthcare providers, independent licensed clinics, and other qualified healthcare professionals. Originally established as Fresh Start Private Management, Inc., the organization officially rebranded as BioCorRx Inc. in January 2014. Its corporate headquarters are situated in Anaheim, California.
Show more...
CEO
Lourdes Felix
Employees
3
Country
United States
ISIN
US09073C2052

Listings

0 Comments

Share your thoughts

FAQ

What is BioCorRx stock price today?
The current price of BICX is $0.21 USD — it has increased by +4.48% in the past 24 hours. Watch BioCorRx stock price performance more closely on the chart.
What is BioCorRx stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BioCorRx stocks are traded under the ticker BICX.
Is BioCorRx stock price growing?
BICX stock has risen by +4.48% compared to the previous week, the month change is a -29.53% fall, over the last year BioCorRx has showed a -53.54% decrease.
What is BioCorRx market cap?
Today BioCorRx has the market capitalization of 6.07M
When is the next BioCorRx earnings date?
BioCorRx is going to release the next earnings report on November 17, 2026.
What is BioCorRx revenue for the last year?
BioCorRx revenue for the last year amounts to 797,000 USD.
What is BioCorRx net income for the last year?
BICX net income for the last year is -3.44M USD.
How many employees does BioCorRx have?
As of September 04, 2026, the company has 3 employees.
In which sector is BioCorRx located?
BioCorRx operates in the Health & Wellness sector.
When did BioCorRx complete a stock split?
The last stock split for BioCorRx was on January 22, 2019 with a ratio of 1:100.
Where is BioCorRx headquartered?
BioCorRx is headquartered in Anaheim, United States.